Cancer combination therapies rely on precise drug interactions - but generic versions may disrupt this balance. Learn why bioequivalence standards fail for multi-drug regimens and what patients and providers need to know.
Read More
Pharmacists should recommend authorized generics for patients with allergies to inactive ingredients, those on narrow therapeutic index drugs, or when consistency matters. They're identical to brand-name drugs but often cheaper-though insurance coverage can vary.
Read More